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ABSTRACT
Background: HIV infection, a multi systemic disease has been identified as one of the 
causes of hearing loss in man. 
Objectives: To compare the effect of HIV infection on the middle ear dynamics of HIV 
infected and non-HIV infected individuals using tympanometry. 
Design: A prospective cross sectional study 
Setting: HIV Clinic at University of Benin Teaching Hospital (UBTH) in 2010.
Subjects: Tympanometry was done on adults (18-45year old) patients with confirmed 
retroviral disease (RVD) infection and confirmed non-HIV infected adults (18-45year 
old) as the control group.  All the patients certified the inclusion and exclusion criteria. 
Main Outcome Measures: More women were found with HIV infection than men at 
a ratio of 1:3.7(men = 21% and females = 79%). There was preponderance of type “B” 
tympanogram among HIV-infected individuals.
Result: There was a significant correlation between CD4 cell count and type “B” 
tympanogram (P=0.03). The CD4 cell count measured severity of HIV infection
while the type “B” tympanogram detected middle ear effusion.
Conclusions: Middle ear effusion is the genesis of middle ear pathology in HIV infected 
population.
INTRODUCTION
HIV is a neurotrophic and lymphotrophic virus 
affecting principally the T- helper lymphocytes (CD4), 
resulting in suppression of cell mediated immune 
response and depletion of T4 lymphocytes (low 
CD4 count). The hallmark of this condition is that it 
predisposes the patient to the risk of opportunistic 
infections (1). Such infections can occur in the ear as 
acute otitis media which may progress into chronicity, 
chronic suppurative otitis media (CSOM) and its 
complications. 
 Hearing loss in HIV patients has been associated 
with other viral infections like cytomegalovirus, 
herpes simplex virus and other bacterial infections 
(2,3,4). A study by Schuknecht and Donovan found 
that temporal bone histopathologic studies of patients 
who experienced idiopathic sudden sensorineural 
hearing loss showed damage in the cochlea consistent 
with viral injuries. The pathologies found in the 
cochlea of these HIV patients include; loss of hair 
cells and supporting cells, atrophy of the tectorial 
membrane, atrophy of the stria vascularis, and 
neuronal loss. There was a similar  findings in  hearing 
loss following mumps, measles, and maternal rubella 
(5).
 The exact mechanism of how the HIV disease 
causes hearing loss is not yet clear. Furthermore, 
controversy on the ototoxic effect of some of the 
antiretroviral therapies has been speculated as an 
independent cause of  hearing loss on patients (6). 
To this end,  the study aims  to determine the effect 
of CD4 count level on the middle ear dynamics of 
HIV infected patient using tympanometer.
MATERIALS AND METHODS
 This study was a prospective cross sectional study 
of young adults (18-45 year old) with confirmed 
retroviral disease (RVD) infection. The study 
population was recruited from consecutive patients 
who attended the HIV Clinic at University of Benin 
Teaching Hospital (UBTH) in 2010. The control group 
was selected from individuals who were tested and 
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confirmed HIV-negative by Voluntary Counseling 
and Testing Section of the HIV Unit, and had no 
symptoms and/or diagnosis of hearing impairment. 
An interviewer administered questionnaire was 
completed for each eligible participant.
Inclusion Criteria: The participants of the study group 
met all the following criteria   
1. HIV infected patients aged between 18 - 45 years.
2. HIV infected patients who gave their informed 
consents to participate in the study. 
The participants of the control group were recruited 
to match the study group in age and sex. They also 
gave consent to participate in the study except that 
they tested negative for HIV I or II
Exclusion Criteria: The following exclusion criteria 
were applied in this study: 
1. HIV positive patients whose ages fall outside the 
range 18 to 45 years. 
2. HIV infected patients whose diagnosis of hearing 
impairment pre-dated the HIV infection. 
3. Patients who refused to give a written consent to 
participate in the study.
Ethical considerations: The study protocol was 
submitted to the Ethical Review Committee of 
UBTH, Benin City and approval was received before 
commencing the data collection.  Eligible participants 
signed informed consent before they were recruited 
into the study. 
Method of Identification of HIV patients: Their HIV 
infection status was confirmed based on the diagnostic 
criteria recommended by United Nations Joint 
Programme on HIV/AIDS (UNAIDS) and World 
Health Organization (WHO) for making a diagnosis of 
HIV infection1. Confirmed HIV I or II positive patients 
using ELISA. First ELISA Screening test was used for 
preliminary identification of patiens followed by a 
confirmatory testing with Western Blot technique.
  
A general clinical examination: A general clinical 
examination was carried out on each person and 
in addition anterior and posterior rhinoscopy was 
done on the patients to rule out any mass that could 
be obstructing eustachain tube. Otoscopy was done 
on every patient using hand held auroscope and 
appropriate sized speculum cleaned with dilute 
hypochloric acid and methylated spirit. Otoscopy 
was used to estimate the diameter of the external 
ear canal and the status of the tympanic membrane 
(TM).This helped to exclude impacted wax, foreign 
body and in addition reveal any ear discharge or 
perforation on the tympanic membrane. Identified 
pathologies were treated or appropriately refered 
for treatment. Peripheral venous blood was obtained 
from the patients for CD4 cell count determination.
Tympanometry: The auditory canal and tympanic 
membrane were examined before tympanometry. 
Large clumps of earwax and squamous debris were 
removed before testing. There are several sizes of 
soft probe tips especially for the different diameters 
of the external auditory canal. The probe tip sizable 
for each EAM was selected for each ear to obtain a 
valid tracing. The ear helix was gently grasped and 
pulled up and backward to straighten out the ear 
canal and allow insertion of the soft probe tip. The 
automatic recording device was triggered, when the 
probe tip was inserted properly and hermetic seal 
achieved. The probe tip was left in position until the 
test was concluded. After a clear tracing was obtained, 
the procedure was repeated in the contralateral ear. 
There was a repeat of the procedure for each of the 
unsatisfactory results. 
 During the test, the patient did not talk, move, 
open or close the jaw, swallow, or startle. 
The CD4 count: The CD4 cell count was done for 
every patient in the study group in the HIV unit of 
UBTH laboratory by the trained personnel who were 
approved and employed for this purpose. The CD4 
cell count was used to stage the severity of the HIV 
disease for the commencement of antiretroviral drugs 
in HIV infected patient
Data Analysis: After the collection of the data the result 
was analysed using descriptive tools in statistical 
package for the social sciences (SPSS). Relationship 
between variables was assessed where necessary 
using Chi-Square and T-test. 
  P-value ≤ 0.05 was considered statistically 
significant. The results were presented in both tabular 
and graphic forms as appropriate.
RESULTS
Out of these 3200 patients seen in the HIV clinic 
during the study, 97 patients were eligible for this 
work based on the inclusion and exclusion criteria 
used. Forty-nine people who tested HIV-negative 
and volunteered to undergo pure tone audiometry 
were used for control matching their age and sex 
with the study group. 
 There were 21 males and 76 females with M:F 
1:4 in the study group (Table 1).  The control group 
was made up of 10 males and 39 females, M:F  1:4 
(Table 1). The age range was 21-45 years. There were 
no eligible 18-20 year old participants. The modal 
age was 31-35 years while the least was 21-25 years 
age (Table 2).The mean age for the study group was 
34 ±7.19 years while that of control group was 35.0 
±5.69 years.  All the participants in the control group 
had no ear symptoms while in the study group, 80 
participants complained of ear symptoms in the right 
and 82 participants complained of ear symptoms in 
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the left  (162 ears complained of ear symptoms). 
Chi-square test shows that there is a mild statistical 
significant relationship (p < 0.05) between CD4 cell 
count and Type B tympanometry.
 Using ANOVA to check for the difference in 
the Tympanometric value for the control and the 
study group shows a statistical significance (P=0.03) 
between the two groups. However, the independent 
t-test for test of statistical significant showed that 
compliance and pressure values were the ones causing 
the difference in the values. Type B tympanometry 
was more predominant than type AS, Type Ad and 
Type C (Table III) in the study group.
DISCUSSION 
Tympanometry is important in the diagnostic 
accuracy for middle ear diseases as shown  in the 
1997 “Guidelines for the Diagnosis and Management 
of Acute Otitis Media (AOM) and Otitis Media with 
Effusion (OME)”7,8. Middle ear pathology is the 
major cause of conductive hearing loss (CHL). This 
study showed that there were preponderance of 
Type “B” and Type “AS”  tympanograms  among the 
HIV infected participants than in the control group 
(Figure 1). Type “B” tympanogram reflects impaired 
compliance or increased impedance of the motion 
of the tympanic membrane over the continuum of 
pressure gradient.
 The type “B” tympanogram can be seen when 
there is a small middle ear effusion . A middle ear 
cavity that contains a large effusion instead of air will 
reflect most of the sound energy backward and have 
a flat line type “B” tympanogram. However, there are 
other conditions that can give type “B” tympanogram 
such as occlusion of the probe tip by cerumen or the 
canal wall. Type “B” tympanogram can also occur 
when there is TM perforation or tympanotomy tube. 
These conditions were ruled out by otoscopy. Any 
middle ear mass, including a cholesteatoma will 
impede transmission of sound energy and may also 
be associated with a type “B”  tympanogram.  Type 
“AS” (s=shallow) tympanogram pattern shows a low 
peak amplitude of TM compliance which suggests 
stiffened middle ear system. The preponderance of 
these findings among HIV infected participants is 
suggestive of a greater predisposition to the formation 
of middle ear pathology that can impede transmission 
of sound wave than in the control group (non-HIV 
infected population).
 Several studies reported that there is reduced 
nasal mucociliary action in HIV infected individuals 
(9, 10, 11). The middle ear having the same 
mucoepitheial lining with the upper air way , may 
be affected equally with the same aetiology. If this is 
possible, it means that middle ear effusion/recurrent 
otitis media with effusion due to the reduced 
mucocilliary action in the middle ear could be the 
major cause of the preponderance of type “B” among 
HIV infected patients. This may also partly explain 
the pathophysiology of middle ear infections that is 
common among HIV sero-positive individuals12,13. 
Chi-square test showed that there was a statistical 
significant relationship (p < 0.05) between CD4 cell 
count and Type B tympanometry that was observed 
in this work (Table III). It may be explained that the 
lesser the CD4 cell count the more the chances of 
the middle ear fluid formation, which will equally 
increase the risk of the patient having conductive 
hearing loss and/or otitis media.  The CD4 cell 
count measured severity of HIV infection while the 
type B tympanogram detected middle ear effusion 
seen with increased severity of HIV infection. The 
findings in this study agrees with previous works 
which show that low CD4 cell count predisposes HIV 
sero-positive patient to a higher risk of developing 
otitis media (14,15,16).
 Type “C” and Type “Ad” was not found among 
the non-HIV infected participants (control group). 
The type “C” tympanogram is similar to type “A” 
but the peak is to the left of normal pressure. It 
indicates extreme eustachian tube dysfunction when 
the pressure peak is less than –300 dePa. Eustachian 
tube dysfunction on its own can lead to middle ear 
effusion which is one of the major problems of the 
HIV infected patients as seen in this study [Table III]. 
The absence of the type “C” tympanogram among the 
control (non-HIV infected) group is a further proof 
that middle ear effusion is a major cause of hearing 
impairment in HIV sero-positive population.
In conclusion, we hereby recommend that there 
should be audiometric and tympanometric routine 
ear assessment and subsequent monitoring for all the 
HIV infected patients. Furthermore, a more sensitive 
advanced refractory acoustic tympanometer that 
can measure volume and density of the middle ear 
fluid should be used for more specific diagnosis of 
the middle ear effusion. Finally, otoacustic emission 
device and brain stem evoked response audiometery 
should be incorporated in the subsequent study to 
help in assessing cochlea and retro-cochlea functions. 
 There was preponderance of type “B” 
tympanogram among HIV-infected individuals 
which correlates significantly with the CD4 cell count 
levels. This work highlights the fact that middle 
ear effusion is commoner among the HIV infected 
population despite the absence of clinical features of 
otitis media in these patients. Therefore middle ear 
effusion is the genesis of the middle ear pathology seen 
among this group and it has an inverse relationship 
with CD4 count. 
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